FDA Approved: MYQORZO — Supplemental Application (Cytokinetics Inc.)

View source ↗

Summary

FDA approved a supplemental application for MYQORZO (aficamten) from Cytokinetics Inc. This action authorizes changes associated with the drug's labeling and/or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• MYQORZO (aficamten)

Snippet

SUPPL AP for MYQORZO (AFICAMTEN)